1. Home
  2. ALBT

as 05-17-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Founded: 2014 Country:
United States
United States
Employees: N/A City: FREEHOLD
Market Cap: 2.9M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 189.8K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.59 EPS Growth: N/A
52 Week Low/High: $0.24 - $2.42 Next Earning Date: 05-28-2024
Revenue: $1,255,681 Revenue Growth: 4.45%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: